$112.66 -0.96 (-0.85%) Celgene Corp - NASDAQ

Jan. 20, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 112.66
Trade Time: Jan 20 04:00 PM Eastern Daylight Time
Change: -0.96 (-0.85%)
Prev Close: 113.62
Open: 114.28
Bid: 112.65
Ask: 112.70
  1. Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen

    Investors Business Daily | Jan. 18, 2017 | 16:33PM EST
  2. Trump Press Conference, Celgene, GW Pharma Lead Investing Action Plan

    Investors Business Daily | Jan. 10, 2017 | 16:08PM EST
  3. Celgene CEO: Drug-Pricing Debate Hinges On Incentives For Innovation

    Investors Business Daily | Jan. 10, 2017 | 13:26PM EST
  4. Stocks Trade Quietly Ahead Of Long Weekend; Biotechs Lead

    Investors Business Daily | Dec. 23, 2016 | 15:07PM EST
  5. Regeneron Likely To Jump On Amgen LDL-Buster, But Expectations Too High

    Investors Business Daily | Dec. 20, 2016 | 15:28PM EST
  6. Johnson & Johnson Boosted By Barron's Call For Rally

    TalkMarkets | Dec. 12, 2016 | 13:00PM EST
  7. Actelion Remains In M&A Spotlight, ASH Data In Focus

    TalkMarkets | Dec. 7, 2016 | 18:01PM EST
  8. S&P 500, Dow Notch All-Time Highs; Dave & Buster's Soars 19%

    Investors Business Daily | Dec. 7, 2016 | 16:07PM EST
  9. Stock Indexes Extend Gains, But Big R&D Biotechs Dive

    Investors Business Daily | Dec. 7, 2016 | 14:04PM EST
  10. Juno Therapeutics (JUNO) Shows Positive Early Data In Leukemia Patients

    TalkMarkets | Dec. 5, 2016 | 09:21AM EST
  11. Bluebird Rockets On Myeloma Drug; Celgene Gets Boost

    Investors Business Daily | Dec. 1, 2016 | 12:10PM EST
  12. Bluebird Bio, Celgene Multiple Myeloma Therapy Shines In 9-Patient Study

    Investors Business Daily | Nov. 30, 2016 | 18:58PM EST
  13. Market Reversal In Biotech But Healthcare Stocks Are Still Muddled

    TalkMarkets | Nov. 29, 2016 | 22:56PM EST
  14. Calithera In Focus, Part 2 - Upcoming Catalysts In TNBC And RCC

    TalkMarkets | Nov. 23, 2016 | 11:45AM EST
  15. Rayno Biobeat #4: Sector Shift Underway But What’s Next For Biotech?

    TalkMarkets | Nov. 23, 2016 | 00:13AM EST
Trading Center